Join
Live feed
·
INSIDERFilingvia Quantisnow
Cogent Biosciences Inc. logo

Chief Legal Officer Kearns Evan sold $2,515,500 worth of shares (65,000 units at $38.70), decreasing direct ownership by 37% to 109,398 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
COGT· Cogent Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track COGT (Cogent Biosciences Inc.) and more on Quantisnow.